SIRT2 and multiple system atrophy: Since endogenous SIRT2 is predominantly found in the cytoplasm of oligodendroglia rather than in that of neurons [60,61,62,63], the inhibition of SIRT2 resulting in tubulin hyperacetylation can be considered as a potential therapeutic approach in MSA.